Syndax Pharmaceuticals Inc (SNDX)
Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025
Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025
Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025
Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer
Clearmind Medicine Successfully Regains Compliance with Nasdaqs Minimum Stockholders Equity Requirement
ImmunityBio Receives Conditional Marketing Authorization Recommendation from the European Medicines Agency for ANKTIVA® with BCG for Non-Muscle Invasive Bladder Cancer Carcinoma in Situ—A First in Europe
West to Participate in Upcoming Investor Conference
Change of Director’s Interest – Tan Kia King (12 Dec 2025)
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
Latest About iPod Nano 7th Generation
Shark FlexStyle vs Dyson Airwrap